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During the last pandemic, experience in the management
of the most severely affected patients with influenza A
(H1N1)-related acute respiratory distress syndrome
(ARDS) included increased use of extracorporeal mem-
brane oxygenation (ECMO) [1, 2]. Growing interest in
this technique has been spurred by the results of a large
cohort study in which transfer to an ECMO center was
associated with lower hospital mortality than matched
non-ECMO-referred patients [3]. To date, it has been
difficult to establish recommendations for ECMO referral,
since neither the type of patients who benefit from this
technique nor the exact timing of the switch from con-
ventional treatment to ECMO have been systematically
investigated [4].
In this issue of Intensive Care Medicine, Grasso et al.
[5] evaluate whether the use of transpulmonary pressure
(PTP) [as opposed to airway pressure (Paw) alone] as a
surrogate of the true lung distending pressure might lead
to safely increased positive end-expiratory pressure
(PEEP) and improved oxygenation, thereby avoiding
unnecessary ECMO. In fact, whereas Paw is influenced
by chest wall properties and respiratory muscle activity,
the PTP (Paw – pleural pressure) enables estimation of
passive lung’s actual distending pressure, unencumbered
by the influence of the chest wall and patient effort on
recorded airway pressures. To assess PTP, an esophageal
balloon catheter was used to estimate global pleural
pressure, a venerable laboratory technique that has
recently been deployed in the clinical setting of lung
protective ventilation [6]. Grasso and colleagues hypoth-
esized that, despite high Paw, the actual PTP observed in
some very severe patients with ARDS might be low
enough to allow safe increases of PEEP and improved
lung recruitment when a relatively large proportion of
Paw dissipates against a stiff chest wall. In the current
study, the authors nicely demonstrated that PTP, as
opposed to unadjusted Paw, effectively guided the
selection of PEEP while keeping end-inspiratory PTP in a
theoretically safe range. Many of the studied patients had
abnormal chest wall elastance related to obesity. Because
the chest wall may account for an unexpectedly high
fraction of total respiratory system elastance even in lung
injured patients, relying on Paw to estimate distension and
guide recruitment may be misleading [7]. Using PTP to
optimize PEEP and tidal volume (Vt) is a particularly
attractive option for influenza A (H1N1) patients with
diffuse ARDS which appears to have occurred dispro-
portionately often in the obese.
Clinical findings have supported the idea that end-
expiratory collapse, inspiratory recruitment, and potential
regional overdistension are continuous and interdepen-
dent phenomena [8]. Nevertheless, the complex
relationship between PTP, recruitment, and the risk of
overdistension has frustrated most attempts to establish
reliable rules with which to govern clinical choices
among options for selecting PEEP and Vt [9].
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Findings reported in this current case series may be
viewed as a partial ‘‘proof of concept,’’ but several
methodological limitations relating to the design and the
reliability of esophageal pressure (Pes) measurement may
limit broader clinical application of this approach to
everyday practice.
First, the authors postulated that 27 cmH2O could
rationally be considered the safe upper limit target for
PTP. Clinical observations supporting this statement are
relatively scarce. In a large group of patients with and
without ARDS, Chuimello et al. investigated the rela-
tionship between stress (i.e., transpulmonary pressure)
and strain defined as the ratio between Vt and end-expi-
ratory lung volume [10]. With imaging data used as the
criterion, the authors demonstrated that plateau pressure
(Pplat) and Vt are imprecise surrogates for lung tissue
stress and strain. The poor relationship they observed
between Pplat and lung distension was related to the
heterogeneous influence of the chest wall. Interestingly,
the stress to strain ratio (i.e., specific elastance) was
remarkably constant (around 13 cmH2O) whatever the
disease severity and combination of PEEP and Vt. Based
on animal studies [11, 12] which suggest that tidal ven-
tilation at strain ratio above 2 (which corresponds to an
end-inspiratory lung volume approaching total lung
capacity) may prove rapidly lethal, the authors proposed
to set the harmful threshold arbitrarily at 27 cmH2O
(2 9 13.5 cmH2O). While this proposal would appear
conceptually sound, the designated criterion value for
PTP is based on animal observations rather than clinical
studies. Moreover, in a clinical study investigating the
chest wall’s contribution to the inspiratory pressure–vol-
ume relationship of the respiratory system during ARDS,
Owens et al. [13] observed relatively little influence. This
may have been due to the fact that most of these patients
suffered from ARDS related to medical illnesses. How-
ever, in patient with ARDS related to intra-abdominal
disease and in those exhibiting high BMI, the chest wall
may account for a much higher proportion of total elas-
tance [14, 15]. In accordance with those observations,
Grasso et al. [5] suggested that targeting Pplat of
30 cmH2O may be excessively prudent in some patients
and may lead to unjustified recommendations for ECMO
management. On the other hand, Terragni et al. [16]
showed in 30 patients managed according to the ARDS
network strategy that one-third experienced tidal hyper-
inflation [assessed by CT scan systematic analysis]
despite a Vt of 6 ml/kg PBW and a Pplat limited at
30 cmH2O. In that study, patients exhibiting Pplat below
28 cmH2O were significantly less prone to hyperinflation.
How to reconcile these contrasting observations suggest-
ing that a 30 cmH2O Pplat may both overestimate
distension and underestimate the true hyperinflation is
challenging without invoking important differences in
lung disease severity and/or chest wall distensibility.
Predicting mechanical properties from traditional obser-
vations of physical examination or airway pressure
measurements is difficult in clinical practice, especially
when disease is unevenly distributed and spontaneous
breathing efforts are permitted or encouraged. In this
context, Pes measurement and transpulmonary pressure
estimation may be essential in differentiating patients
who may benefit from a PEEP increase because of
increased chest wall elastance from those at risk of hy-
perdistension despite relatively low Paw. Yet, the true
tension experienced in the alveolar micro-environment
may only be crudely represented by the PTP, however
accurate the latter might be measured.
The second point that merits discussion concerns the
potential impact of higher PEEP levels on hemodynamics.
The physiological rationale of the study reported by
Grasso et al. relied on the fact that ECMO is a rescue
therapy that should be avoided whenever possible. Sup-
posing that this statement is correct, the consequence of
avoiding ECMO according to their strategy (considered
safe as regards to end-inspiratory PTP) will be a poten-
tially major increase of PEEP. Therefore, one price to pay
that should be considered in avoiding ECMO’s drawbacks
is the possible impact of greater lung distension and
higher pleural pressure on hemodynamic status. The same
group of authors have shown several years ago that
recruitment maneuvers were significantly less efficient
(and potentially harmful) in patient exhibiting high chest
wall elastance compared with ARDS in which the chest
wall was not altered [17]. Predictably, the authors
observed in this study a significantly larger impact of Paw
on cardiac output in the group of patients with higher
chest wall elastance. This harmful hemodynamic effect
(which in addition did not result in oxygenation
improvement) expected in patients with high chest wall
elastance should be considered as a possible price to pay
for a strategy based on PTP measurement to increase
PEEP in order to avoid ECMO requirement.
Finally, before we can embrace Pes as an accurate
surrogate for the pressure that surrounds the lung, we
must understand that the esophageal balloon catheter
measures the least pressure in its local environment, and
that this pressure may vary considerably from that exist-
ing elsewhere. Even locally, the sensitivity of Pes to
changes in abdominal pressure and lung volume is suspect
at end exhalation [18].
Despite numerous shortcomings, the option to sense
pleural pressure at the bedside by an esophageal balloon
represents the next logical step in a more physiological
and individually tailored approach to lung protective
ventilation.
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